Live feed
Filing
SC 13G
SC 13G0001422848-22-000229·Capital Research Global Investors
Schedule 13G ownership disclosure
Haemonetics Corp
Security class unavailable · CUSIP: 405024100
Event date: 2022-03-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,452,006
- Percent of class
- 10.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001422848-22-000229
- Form type
- SC 13G
- Filer
- Capital Research Global Investors
- CIK
- CIK 1422848
- Filed
- Apr 08, 2022
- Reporting period
- Mar 31, 2022
- Description
- Schedule 13G beneficial ownership